Skip to main content

Table 1 Baseline demographic characteristics in the per-protocol population

From: A novel read methodology to evaluate the optimal dose of 68Ga-satoreotide trizoxetan as a PET imaging agent in patients with gastroenteropancreatic neuroendocrine tumours: a phase II clinical trial

Parameter

Arm A (N = 8)

Arm B (N = 8)

Arm C (N = 8)

Overall (N = 24)

Age, years

71.5 (54–84)

65.5 (60–72)

60.5 (48–76)

62.5 (48–84)

Sex

    

 Male

6 (75.0)

3 (37.5)

7 (87.5)

16 (66.7)

 Female

2 (25.0)

5 (62.5)

1 (12.5)

8 (33.3)

Body weight, kg

81.0 (77–98)

87.5 (52–109)

87.5 (60–105)

85.0 (52–109)

Height, cm

175.5 (162–189)

171.0 (159–185)

177.5 (171–189)

176.0 (159–189)

BMI, kg/m2

26.4 (24–35)

28.8 (21–34)

26.6 (19–31)

26.7 (19–35)

ECOG performance status

 0 (normal activity)

7 (87.5)

7 (87.5)

7 (87.5)

21 (87.5)

 1 (restricted activity)

1 (12.5)

1 (12.5)

1 (12.5)

3 (12.5)

  1. Data are presented as n (%) or median (range). Percentages are calculated as n/N
  2. BMI body mass index, ECOG Eastern Cooperative Oncology Group